Literatur
Keller K, Hobohm L, Ebner M et al. Trends in thromolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J. 2019; https://doi.org/10.1093/eurheartj/ehz236
Lankeit M, Konstantinides S. Is it time for home treatment of pulmonary hypertension? Eur Respir J. 2012;40:742–49
Zondag W, Kooiman J, Klock FA et al. Outpatient versus inpatient treatment in patients with pulmonary embolism: A meta analysis. Eur Respir J. 2013;42:134–44
Konstandinides SV, Torbicki A, Agnelli G et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033–80
Buller HR, Prins MH, Lensin AW et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366:1287–97
Originalie
Barco S, Schmidtmann I, Ageno W et al. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial. Eur Heart J. 2019; https://doi.org/10.1093/eurheartj/ehz367
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Skowasch, D. Niedriges Risiko nach Lungenembolie? Frühe Klinikentlassung oft möglich. Pneumo News 11, 17–18 (2019). https://doi.org/10.1007/s15033-019-1240-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-019-1240-8